Study rationale and design of ADVANCE: action in diabetes and vascular disease--preterax and diamicron MR controlled evaluation
(Q43763511)
scientific article
scientific article
Language:
Current Data About
Study rationale and design of ADVANCE: action in diabetes and vascular disease--preterax and diamicron MR controlled evaluation
| (P31) |
(Q13442814)
|
||||||||||||
| (P304) |
1118-1120
|
||||||||||||
| (P433) |
9
|
||||||||||||
| (P478) |
44
|
||||||||||||
| (P577) |
Saturday, September 1, 2001
|
||||||||||||
| (P1433) |
(Q5270140)
|
||||||||||||
| (P1476) |
"Study rationale and design of ADVANCE: action in diabetes and vascular disease--preterax and diamicron MR controlled evaluation" (language: en)
"Study Rationale and Design of ADVANCE: Action in Diabetes and Vascular disease - preterax and diamicron MR controlled evaluation" (language: en) |
||||||||||||
| (P2093) |
ADVANCE Management Committee
Not Available Not Available
ADVANCE Management Committee
|
other details
| aliases |
Study Rationale and Design of ADVANCE: Action in Diabetes and Vascular disease - preterax and diamicron MR controlled evaluation |
| description | scientific article |
External Links
| (P356) |
10.1007/S001250100612
|
| (P698) |
11596665
|